Exploring the Immunogenicity of Noncanonical HLA-I Tumor Ligands Identified through Proteogenomics
Clin Cancer Res. 2023 Jun 13;29(12):2250-2265. doi: 10.1158/1078-0432.CCR-22-3298.ABSTRACTPURPOSE:…
1,4-dihydroxy quininib modulates the secretome of uveal melanoma tumour explants and a marker of oxidative phosphorylation in a metastatic xenograft model
Front Med (Lausanne). 2023 Jan 9;9:1036322. doi: 10.3389/fmed.2022.1036322.…
canSAR: update to the cancer translational research and drug discovery knowledgebase
Nucleic Acids Res. 2023 Jan 6;51(D1):D1212-D1219. doi: 10.1093/nar/gkac1004.ABSTRACTcanSAR…
Systemic cellular viroimmunotherapy for canine high-grade gliomas
J Immunother Cancer. 2022 Dec;10(12):e005669. doi: 10.1136/jitc-2022-005669.ABSTRACTBACKGROUND:…
One-year breakthrough SARS-CoV-2 infection and correlates of protection in fully vaccinated hematological patients
Blood Cancer J. 2023 Jan 5;13(1):8. doi: 10.1038/s41408-022-00778-3.ABSTRACTThe…
Biomarkers of tumor-reactive CD4+ and CD8+ TILs associate with improved prognosis in endometrial cancer
J Immunother Cancer. 2022 Dec;10(12):e005443. doi: 10.1136/jitc-2022-005443.ABSTRACTBACKGROUND:…
Haploidentical Versus Matched Unrelated Donor Transplants Using Post-Transplantation Cyclophosphamide for Lymphomas
Transplant Cell Ther. 2023 Mar;29(3):184.e1-184.e9. doi: 10.1016/j.jtct.2022.11.028.…
An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia
Transplant Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013.…
Metabolomic and Mitochondrial Fingerprinting of the Epithelial-to-Mesenchymal Transition (EMT) in Non-Tumorigenic and Tumorigenic Human Breast Cells
Cancers (Basel). 2022 Dec 16;14(24):6214. doi: 10.3390/cancers14246214.ABSTRACTEpithelial-to-mesenchymal…
Silibinin Overcomes EMT-Driven Lung Cancer Resistance to New-Generation ALK Inhibitors
Cancers (Basel). 2022 Dec 11;14(24):6101. doi: 10.3390/cancers14246101.ABSTRACTEpithelial-to-mesenchymal…
Corrigendum to “Pembrolizumab plus Olaparib in Patients with Metastatic Castration-resistant Prostate Cancer: Long-term Results from the Phase 1b/2 KEYNOTE-365 Cohort A Study” [Eur Urol 83 (2023) 15-26]
Eur Urol. 2023 Mar;83(3):e87. doi: 10.1016/j.eururo.2022.11.025.…
Glofitamab for Relapsed or Refractory Diffuse Large B-Cell Lymphoma
N Engl J Med. 2022 Dec 15;387(24):2220-2231. doi: 10.1056/NEJMoa2206913.…
